GGrantIndex
Sort

50,496 grants matching lung cancer

Angiogenesis in the Lung

$412,586
Elizabeth Wagner · Johns Hopkins University · R01 · FY2010 · HL

Activation of latent TGF-beta by integrins

$412,571
John S. Munger · New York University School Of Medicine · R01 · FY2006 · HL

Altered Lipid Metabolism as a Novel Target for Colon Cancer Treatment

$412,552
Bernard Mark Evers · University Of Kentucky · R01 · FY2019 · CA

SOUTHWEST ONCOLOGY GROUP--SUMMARY

$412,516
Loyola University Chicago · U10 · FY2000 · CA

Inhibition of Radiation-Induced Coronary Microvascular Disease

$412,515
Saraswati Pokharel · Roswell Park Cancer Institute Corp · R01 · FY2022 · HL

Fibroblasts Support the Growth of Brain Metastasis by Rendering Cancer Cells Resistant to Chemotherapy and Inducing Immunosuppression in Tumor Microenvironment

$412,500
Zeng-Jie Yang · Research Inst Of Fox Chase Can Ctr · R01 · FY2025 · CA

Products of the Transforming Genes of Polyomavirus

$412,500
Brian S Schaffhausen · Tufts University Boston · R01 · FY2011 · CA

Products of the Transforming Genes of Polyomavirus

$412,500
Brian S Schaffhausen · Tufts University Boston · R01 · FY2012 · CA

Products of the Transforming Genes of Polyomavirus

$412,500
Brian S Schaffhausen · Tufts University Boston · R01 · FY2015 · CA

Fibroblasts Support the Growth of Brain Metastasis by Rendering Cancer Cells Resistant to Chemotherapy and Inducing Immunosuppression in Tumor Microenvironment

$412,500
Zeng-Jie Yang · Research Inst Of Fox Chase Can Ctr · R01 · FY2023 · CA

Endoglin: A Novel Target of Therapy for Right Heart Failure

$412,500
Navin Kumar Kapur · Tufts Medical Center · R56 · FY2015 · HL

Hydrolytic enzymes in the metabolism of toxins

$412,465
Bruce D Hammock · University Of California At Davis · R01 · FY2016 · ES

Project 2: Near-Infrared Targeted Tracers for Intraoperative Identification of NSCLC

$412,464
Philip Stewart Low · University Of Pennsylvania · P01 · FY2023 · CA

Functional Image and Molecular Marker to Individualize Adaptive Radiation Dose Es

$412,457
Feng-Ming P. Kong · University Of Michigan At Ann Arbor · R01 · FY2011 · CA

Immunological Complications of Radiation Combined Injury

$412,408
James A. Lederer · Brigham And Women'S Hospital · R33 · FY2010 · AI

IL-2 Family Cytokines and their Receptors--Biology of the IL-7/TSLP Systems

$412,394
Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL

Targeting Focal Adhesion Kinase to Improve RT-inducted Tumor Immunity

$412,324
David G Denardo · Washington University · R01 · FY2024 · CA

EASTERN COOPERATIVE ONCOLOGY GROUP

$412,310
Daniel George Haller · University Of Pennsylvania · U10 · FY2010 · CA

In vivo therapy and mechanisms of PAX8-PPARgamma thyroid cancer

$412,268
Ronald Jay Koenig · University Of Michigan At Ann Arbor · R01 · FY2017 · CA

Erythropoietin Blockade for the Treatment of Cancer

$412,263
C. Anthony Blau · University Of Washington · R01 · FY2010 · CA

Modulation of Mcl-1 for Treatment of Lung Cancer

$412,210
Xingming Deng · Emory University · R01 · FY2024 · CA

In vivo murine models of metastasis for therapeutic testing

$412,209
Norman Edward Sharpless · Univ Of North Carolina Chapel Hill · R01 · FY2012 · CA

Platelet Serine/Threonine Phosphatases in Cancer Pathophysiology

$412,172
K. Vinod Vijayan · Baylor College Of Medicine · R01 · FY2022 · CA

Preventive Interventions Leadership U01

$412,163
Samir M Hanash · Fred Hutchinson Cancer Research Center · U01 · FY2010 · CA

Endometrial epithelial stem cells and cancer

$412,143
Alexander Y Nikitin · Cornell University · R01 · FY2024 · CA